However, allogenic hematopoietic stem cell transplantation (HSCT) is the current therapeutic strategy to efficiently treat DOCK8 deficiency related diseases. The gene discussed is DOCK8; the disease is hyperinsulinemic hypoglycemia, familial, 4.